| 000 | 01637 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511182523.0 | ||
| 264 | 0 | _c19921118 | |
| 008 | 199211s 0 0 eng d | ||
| 022 | _a1055-7172 | ||
| 024 | 7 |
_a10.3109/10731199209119686 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurhop, K E | |
| 245 | 0 | 0 |
_aEffects of intravenous infusions of diaspirin cross-linked hemoglobin (DCLHb) on sheep. _h[electronic resource] |
| 260 |
_bBiomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology _c1992 |
||
| 300 |
_a581-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAspirin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBlood Substitutes _xadministration & dosage |
| 650 | 0 | 4 |
_aComplement C3a _xmetabolism |
| 650 | 0 | 4 | _aCross-Linking Reagents |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemoglobins _xadministration & dosage |
| 650 | 0 | 4 |
_aInflammation _xetiology |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aSerum Albumin _xadministration & dosage |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 |
_aThromboxane B2 _xblood |
| 700 | 1 | _aFarrell, L | |
| 700 | 1 | _aNigro, C | |
| 700 | 1 | _aTan, D | |
| 700 | 1 | _aEstep, T | |
| 773 | 0 |
_tBiomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology _gvol. 20 _gno. 2-4 _gp. 581-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10731199209119686 _zAvailable from publisher's website |
| 999 |
_c1397977 _d1397977 |
||